Stock listing
NASDAQ:HPTX Hyperion Therapeutics Inc Stock
Follow Hyperion Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:HPTX
$45.99 USD
Close on May 7, 2015 · No longer trades
- Lowest – highest close
- $10.04 – $46.14 USDSince Jul 26, 2012 · lowest Aug 17, 2012 · highest Apr 21, 2015
Delisted NASDAQ:HPTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:HPTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Daniel G. Welch Other companies: Prothena Corporation plc (Chair of the Board · Since at least Feb 21, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Ultragenyx Pharmaceutical Inc. (Director · Since at least Apr 8, 2015); Nuvation Bio Inc. (Director · Feb 10, 2021 – May 24, 2024 · Past); AveXis Inc (Director · Feb 10, 2016 – May 15, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – May 28, 2020 · Past); Corium International Inc (Director · Apr 2, 2014 – Apr 2, 2014 · Past); Seagen Inc (Director · Jun 13, 2007 – Dec 14, 2023 · Past); InterMune Inc (Chairman, CEO and President, Director · Mar 15, 2006 – Sep 29, 2014 · Past) | Director · Aug 23, 2012 – May 7, 2015 · Past |
| Lota S Zoth Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Lumos Pharma Inc (Director · Nov 2, 2012 – Dec 12, 2024 · Past); Orexigen Therapeutics Inc (Director · Apr 26, 2012 – Jul 14, 2017 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Jul 25, 2012 – May 7, 2015 · Past |
| Theodore R Schroeder Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 16, 2025); Cidara Therapeutics Inc (Director · Since at least Apr 14, 2015); Nabriva Therapeutics AG (Director · Jul 24, 2018 – Jan 29, 2023 · Past); Collegium Pharmaceutical, Inc. (Director · Jan 22, 2016 – May 20, 2020 · Past); Otonomy Inc (Director · Aug 28, 2015 – Jun 21, 2022 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (President, CEO, Director · Oct 24, 2006 – Mar 19, 2014 · Past) | Director · Aug 11, 2014 – May 7, 2015 · Past |
| Jeffrey Farrow Other companies: Achieve Life Sciences, Inc. (Director · Since at least May 29, 2026); Tarsus Pharmaceuticals, Inc. (See Remarks · Since at least Apr 24, 2023); Lisata Therapeutics, Inc. (Director · Since Oct 13, 2026 · Appointed, no departure found); Global Blood Therapeutics Inc (Chief Financial Officer · Apr 4, 2016 – Oct 5, 2022 · Past); ZS Pharma Inc (Chief Financial Officer · Jul 8, 2015 – Dec 17, 2015 · Past); Renovis Inc (V.P., Finance and CAO · Jul 1, 2007 – May 2, 2008 · Past) | CFO · Jul 25, 2012 – May 7, 2015 · Past |
Log in to ask 6ix AI your own questions about Hyperion Therapeutics Inc.